471 funding opportunities found on ScanGrants, 30 of which were added this week. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Call for Nominations: Henry W. Elliott Distinguished Service Award
The Henry W. Elliott Distinguished Service Award was established in 1979 to recognize an ASCPT member who has gone above and beyond the call of duty in service to the organization.
The goal of the Henry W. Elliott Distinguished Service Award is to acknowledge outstanding efforts on behalf of the organization by an individual member and in doing so, encourage other ASCPT members to contribute their time and talent to the Society.
Eligibility
A nominee must be a member of ASCPT and cannot have held the position of President-Elect or President of the Society within the last five years. The essential criterion documented evidence of excellent service to the organization. One or two outstanding acts of service or a long record of many acts of service may justify the award. The recipient should have a record of continuous service to the Society, including one or many major accomplishments.
Prize and Presentation
The Henry W. Elliott Distinguished Service Award is presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
The nomination deadline is Thursday, June 27, 2013.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at meetings@ascpt.org.
Call for Nominations: Sheiner-Beal Pharmacometrics Award
The Sheiner-Beal Pharmacometrics Award has been established as an ASCPT Award by the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF) to acknowledge the pioneering contributions of Drs. Lewis B. Sheiner and Stuart Beal to the scientific discipline of pharmacometrics.
Definition
Pharmacometrics is defined as the science that quantifies drug, disease and clinical trial information to aid efficient drug development, regulatory decisions and rational therapeutic decision making in patients. It uses models that are generally based on pharmacology, physiology, genetic constitution and/or disease for quantitative analysis of interactions between drugs and patients. The domain of pharmacometrics includes the application of techniques that address the interactions between pharmacokinetics, pharmacodynamics, pharmacogenomics, and disease progression with a focus on populations and variability in the exposure-response relationship.
Goal
The goal of the Sheiner-Beal Pharmacometrics Award is to recognize outstanding achievements at the forefront of research or leadership in pharmacometrics and/or application of pharmacometric concepts and techniques to enhance research, development, regulatory evaluation, and/or utilization of therapeutic products.
The candidate must be an investigator or leader who is actively advancing the scientific discipline of pharmacometrics and/or its impact on research, development, regulatory evaluation, or utilization of therapeutic products, and is capable of delivering an engaging and comprehensive lecture on pharmacometrics. The award is intended to recognize clinical pharmacologists, clinician scientists, computational scientists, statisticians and others in academia, industry, government agencies, or consulting whose work falls within the scope of the definition of pharmacometrics.
The Sheiner-Beal Pharmacometrics Award will be presented annually at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient will receive a $1,500 honorarium and a plaque. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Call for Nominations: Leon I. Goldberg Young Investigator Award
The Leon I. Goldberg Young Investigator Award was established in 1986 to honor a young scientist for accomplishments in the field of clinical pharmacology achieved early in his/her career.
The goal of the Leon I. Goldberg Young Investigator Award is to encourage and recognize young scientists active in the field of clinical pharmacology.
There are no restrictions concerning the scientific field in which nominees have earned their doctoral degrees. Nominees must be no more than 45 years of age as of March 1 of the year in which the award is presented. Although it is encouraged, a nominee need not be a member of the Society.
The Leon I. Goldberg Young Investigator Award is presented at the ASCPT Annual Meeting. The recipient will deliver a lecture on his/her work. In addition, the recipient of the award will receive a plaque and a $1,000 honorarium. Travel expenses, hotel expenses and meeting registration are reimbursed by the Society.
Call for Nominations: Gary Neil Prize for Innovation in Drug Development
The Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies.
The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area.
Individuals as well as teams who have demonstrated leadership in the application of significant, innovative science to clinical drug development. The award is open to individuals from all clinical pharmacology employment sectors.
The Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
To submit a nomination, please complete the online nomination form. Please send CVs, letters of support, and other supporting documents to ASCPT at meetings@ascpt.org
Call for Nominations: Oscar B. Hunter Memorial Award in Therapeutics
The Oscar B. Hunter Memorial Award in Therapeutics was established in 1955 to honor individual scientists for outstanding contributions to clinical pharmacology and therapeutics. This award recognizes a meritorious career in drug research, excellence or contributions in direct patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is the Society's premier award. The goal of the award is to honor a scientist for outstanding contributions to clinical pharmacology and therapeutics over the individual's professional life.
A nominee must be able to provide evidence of an exemplary career in drug research, significant contributions to excellence in patient care, and a distinguished teaching career.
The Oscar B. Hunter Memorial Award in Therapeutics is presented at the ASCPT Annual Meeting. The recipient will present a lecture summarizing the works that form the basis of the award. In addition, the recipient of the award will receive a bronze medal mounted on a plaque and a $1,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Rosalinde Gilbert Innovations in Alzheimer’s Disease Caregiving Legacy Awards
With continuing support from The Rosalinde and Arthur Gilbert Foundation, Family Caregiver Alliance (FCA) is pleased to oversee the annual Rosalinde Gilbert Innovations in Alzheimer's Disease Caregiving Legacy Awards program in its sixth year.
Three awards of $20,000 each will be awarded to nonprofit organizations, government agencies or universities responding to a community need with a program or project which focuses primarily on family/informal caregivers of adults with Alzheimer's disease and related dementias. Only agencies operating within the continental United States are eligible to apply. One award will be granted in each of these categories:
Creative Expression: This award will go to programs or projects that use imaginative and creative approaches in supporting persons with dementia or family/informal caregivers of persons with Alzheimer's disease and related dementias. Some examples are programs or projects using art, music, theatre, journaling, multimedia (e.g. film, documentary, radio) or other types of creative expression.
Diverse/Multicultural Communities: This award will go to programs or projects that provide services, support or other types of outreach to family/informal caregivers of persons with Alzheimer's disease or related dementias in diverse ethnic, age diversity, religion/spirituality, gender, rural, low income, and LGBT or other communities.
Policy and Advocacy: This award will go to programs or projects that advocate for systems change for the benefit of family/informal caregivers or care recipients with Alzheimer's disease or related dementias. These efforts could focus on legislation, executive or administrative changes, advocacy campaigns, or any other action to strengthen the public or private sector's recognition and support of family/informal caregivers.
Award Timeline
Applications are available, online only. The closing deadline for 2013 applications is 5 p.m. (Pacific Time), Friday, August 16, 2013. Award announcements will be made by late November 2013. Award recipients will be honored at the 2014 Annual Conference of the American Society on Aging (ASA). Participates will be invited to present information about their awarded program or project at the conference. Travel stipends will be available for the conference.
Eligibility and Submission Conditions
Nonprofit organizations, government agencies and universities responding to a community need with a program or project that focuses primarily on family/ informal caregivers of adults with Alzheimer's disease and related dementias are eligible to apply. Family or informal caregivers are unpaid caregivers. The term includes family members, friends, domestic partners and neighbors. Support for family/informal caregivers need not be the primary mission of the organization, agency or university.
Nonprofit applicants must submit proof of their 501(c) (3) status or other nonprofit status by attaching a copy of their nonprofit designation letter to their application. For-profit entities are not eligible to apply.
The nominated program or project has to have been active during the calendar year of 2012 and/or 2013. If the program or project involves a major culminating event, that event must have occurred prior to application deadline.
For the Policy & Advocacy and Creative Expression categories, program or project may be related to either family/informal caregivers or persons with dementia or both.
For the Diversity/Multicultural Communities category, program/project must be specific to family/informal caregivers of persons with Alzheimer's disease or related dementias.
The applicant or other designated program or project representatives must be willing to share information about their program with others, including a presentation at a national professional conference, and to write up additional information to appear on FCA's website and/or future publications. Award recipients may also be asked to provide information about how the award was used to further advance the mission of the organization, agency, or university.
Application must be received by the extended deadline of 5 p.m. (Pacific Time), on Friday, August 16, 2013.
Applicants must apply electronically using the designated online system.
Applicants must designate the category in which they would like to be considered. Applicants are competing only against others within their chosen category. If the judges feel that the applicant would be better suited for another category, they will contact the applicant directly.
Cystinosis Foundation Deanna Lynn Potts Scholarship
Deanna Lynn Potts was born with Cystinosis and lived to be 27 years old. Before she died, she discussed her wishes to start a scholarship fund for children with Cystinosis.
We know how devastating a chronic illness can have on a family emotionally, physically, socially, and financially. Children with Cystinosis are living longer, thanks to medical science and therefore, embarking on careers.
These careers require education. Education is expensive, yet something we do not want to deprive our children of in our world today. Due to the financially draining medical costs, it might prove difficult to send a child to college.
Through this fund, we hope to help some of those students.
PURPOSE: To provide supplemental financial assistance to an undergraduate student diagnosed with Cystinosis enrolled in an accredited collegiate or vocational program.
SCHOLARSHIP AWARD: A $1000 scholarship awarded annually. The award is contingent upon the winners acceptance to an accredited college, university, or vocational program and will be payable to the education institution to be applied to tuition, room and board.
ELIGIBILITY: Each candidate must be a current high school senior, who has Cystinosis and have a financial need.
APPLICATION PROCEDURE:
Documentation/verification of Cystinosis (e.g. letter from physician.)
An official copy of high school transcript.
Two letters of recommendation from current teachers/faculty members and/or counselors regarding applicant's scholastic aptitude and personal qualifications.
An essay of 500 words. We want to know a person who has played a vital role in student's life. How? Why? The essay should be typewritten and double spaced
A copy of the previous year's income tax return.
JUDGING CRITERIA: The essay will earn a possible 40 points and will be judged on the basis of rationale, grammar and comprehension. Transcripts and letters of recommendation will carry a possible additional 20 points. The Cystinosis Foundation Board will establish an independent judging panel to evaluate and rate the applicants. The decision of the judges is final. Finalists may be interviewed before selection is made.
DEADLINE FOR APPLICATION: Application and all accompanying documents must be received at the Cystinosis Foundation Office in a single, flat package by March 30th of each year. You can call the Cystinosis Foundation for an application 888-631-1588.
Remember, the deadline for receiving applications is March 30th of each year.
Request for Application: Cutaneous Lymphoma Foundation’s CLARIONS Research Awards Program
The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions. This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research. These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.
Research Funding Priorities
Eligibility and Requirements
Investigators at all levels, from clinical and post-doctoral fellows to established investigators, are eligible to receive awards. Medical students and graduate students are not eligible. Non-U.S. investigators are eligible and the research funded by the RAP can be conducted at non-U.S. institutions. Investigators must be members of an established and recognized academic institution. All research projects involving human subjects must receive IRB approval.
Award Amounts
Each year the CLF will provide two $25,000 awards, renewable for 1 year contingent upon approval by the CLF Board of Directors based upon the CLF Scientific Review Board’s review and recommendation.
A small indirect cost amount between $1,000-$2,000 is allowable.
The CLF’s RAP seeks to fund innovative research in all areas of cutaneous lymphomas with particular interest in:
-- Etiology and risk factors of cutaneous lymphomas.
-- Measures of disease impact on individuals and populations affected by cutaneous lymphomas.
-- Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas.
-- Optimizing therapies for cutaneous lymphomas.
-- Improving quality of life for individuals with cutaneous lymphomas
2013 Calendar of Award Events
January 31 - Public announcement of Request for Application (RFA)
July 31 - Application deadline
August - October - Scientific Review Board review
November - Recipients notified of award
December - Grant awards announced at ASH meeting
January, 2014 - Disbursement of Award and beginning of new award cycle
Cutaneous Lymphoma Foundation PO Box 374 Birmingham, MI 48012-0374
Telephone: 248-644-9014
Fax: 248-644-9014
Call for Research Grant Applications: Cicatricial Alopecia Research Foundation
The Cicatricial Alopecia Research Foundation (CARF) seeks original, focused, and innovative research grant applications dealing with primary cicatricial alopecia (PCA). Applications will be accepted from laboratories around the world. The proposed project must serve to further CARF's research goals, namely, to understand the pathogenesis of PCA, an understanding that will lead to effective prevention and therapy. CARF will give priority to research proposals based on the following topics.
Role of lipids and lipid metabolism in normal hair follicle stem cell biology and cycling
Role of PPARs and other lipid regulators in the pathogenesis of PCA
Role of peroxisomes in hair follicle biology
Role of neuroinflammation in PCA
Role of environmental triggers in the pathogenesis of PCA
Function of sebaceous glands in normal hair follicle biology.
Mechanism of hair shaft egress from the terminal hair follicle
Hair follicle regeneration in a site of tissue repair
GUIDELINES: All applications for grant requests should clearly state research goals, rationale, brief background, and brief experimental protocol. The planned study may not exceed two years in duration. Included in the submission should be a discussion of anticipated results and their potential significance to understanding PCA. Typical awards are $5,000 to $20,000.
A final progress report must be submitted at the end of the funding period. A progress report must be submitted at the end of the first year to obtain a second year no-cost extension. CARF must be acknowledged on all presentations and publications resulting from CARF funded grants.
Applications are reviewed and funded on an annual basis.
Annual application deadline: March 15. Funding decisions made by June 15.
Call for Nominations: 2013 National Institute of Statistical Sciences' Jerome Sacks Award for Outstanding Cross-Disciplinary Research
Deadline June 15, 2013
Nominations are sought for the 2013 National Institute of Statistical Sciences' (NISS) Jerome Sacks Award for Outstanding Cross-Disciplinary Research. The prize recognizes sustained, high-quality cross-disciplinary research involving the statistical sciences. The prize of $1,000 will be presented at the NISS/SAMSI JSM Reception on August 5, 2013, in Montreal.
To nominate an individual, please submit a nomination letter (maximum two pages, include names of at least two other individuals who have consented to write letters of support) and a CV, to sacksaward2013@niss.org
Further information about the award can be found at:
www.niss.org/news/awards/jerome-sacks-award-outstanding-cross-disciplinary-research
prev123456789101112...48next
